Dr. Nadolsky responds to a clip from comedian @stavvybaby2 about GLP-1s, adding a doctor's view to the joke.
Recap by typeshit. Post by @drnadolsky on Instagram.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
He calls GLP-1 drugs useful before surgery or after regain, but says surgery stays the main option for people who need large, lasting weight loss.
An anonymous poster says people put their dramatic weight loss down to their mother's death, when it was really Ozempic they wanted to keep quiet.
A short social post frames the semaglutide molecule as the start of a bigger business story for drugmakers, with a note that it is not medical advice.
Doctors describe a patient who developed a bowel obstruction after moving from tirzepatide to semaglutide unsupervised, following a long break in treatment.
PIX11 reports the recall covers 23 compounded GLP-1 vials because there is no assurance they are sterile. Check the list if you use compounded shots.
Loading…